FLT3 and acute myeloid leukemia: Based on the dBMA Treg median value (14/μL), the following did not show any correlation with dBMA Treg values ≤ 14/μL: age, WBC, molecular-cytogenetics risk, the NPM mutation, the FLT3 ITD or D835 mutation, and the secondary AML (Table 2).